Form 8-K - Current report:
SEC Accession No. 0001437749-25-015839
Filing Date
2025-05-09
Accepted
2025-05-09 17:00:27
Documents
15
Period of Report
2025-05-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20250509_8k.htm   iXBRL 8-K 20245
6 mbrx20250509_8kimg001.jpg GRAPHIC 5116
  Complete submission text file 0001437749-25-015839.txt   171345

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20250509.xsd EX-101.SCH 3578
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20250509_def.xml EX-101.DEF 11423
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20250509_lab.xml EX-101.LAB 15309
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20250509_pre.xml EX-101.PRE 11583
17 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20250509_8k_htm.xml XML 2846
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 25931431
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)